Charles Marshall, Professor of Clinical Neurology at Queen Mary University of London, said of the study: “The hope is that blood tests like this will improve access to a diagnosis in those seeking help for memory problems, and ultimately ensure that people can benefit from emerging treatments that can slow the progression of Alzheimer’s disease.
